V Di Marzo Selected Research

Edema (Dropsy)

5/2003	Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
11/2001	Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Di Marzo Research Topics

Disease

15	Inflammation (Inflammations) 11/2019 - 04/2000
12	Obesity 06/2016 - 04/2001
9	Pain (Aches) 01/2016 - 04/2000
7	Body Weight (Weight, Body) 04/2015 - 02/2003
5	Insulin Resistance 05/2013 - 07/2008
4	Multiple Sclerosis 12/2013 - 06/2000
4	Neoplasms (Cancer) 12/2001 - 01/2000
3	Chronic Pain 01/2016 - 11/2000
3	Glucose Intolerance 04/2015 - 02/2009
3	Schizophrenia (Dementia Praecox) 01/2014 - 10/2008
3	Type 2 Diabetes Mellitus (MODY) 05/2013 - 11/2007
3	Catalepsy 12/2000 - 10/2000
2	Visceral Pain 12/2017 - 05/2011
2	Dermatitis 01/2016 - 06/2010
2	Weight Loss (Weight Reduction) 07/2014 - 08/2008
2	Huntington Disease (Huntington's Disease) 10/2013 - 07/2001
2	Parkinson Disease (Parkinson's Disease) 08/2012 - 07/2000
2	Vomiting 08/2012 - 05/2007
2	Infections 03/2011 - 04/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2008 - 05/2008
2	Feeding and Eating Disorders (Eating Disorder) 08/2007 - 04/2006
2	Hyperalgesia 03/2007 - 05/2000
2	Edema (Dropsy) 05/2003 - 11/2001
2	Breast Neoplasms (Breast Cancer) 08/2001 - 01/2000
2	Glioma (Gliomas) 04/2001 - 11/2000
2	Hypothermia 11/2000 - 10/2000
2	Prostatic Neoplasms (Prostate Cancer) 04/2000 - 01/2000
1	Ulcerative Colitis 11/2019
1	Mental Disorders (Mental Disorder) 01/2018
1	Dysbiosis 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Morbid Obesity 01/2017
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2017
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2016
1	Neuralgia (Stump Neuralgia) 08/2015
1	Constipation 06/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2013
1	Colitis 05/2013

Drug/Important Bio-Agent (IBA)

38	EndocannabinoidsIBA 12/2017 - 01/2000
21	anandamide (arachidonylethanolamide)IBA 12/2017 - 01/2000
21	CannabinoidsIBA 07/2014 - 01/2000
13	palmidrolIBA 01/2017 - 04/2000
12	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2017 - 01/2000
10	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2011 - 01/2000
7	RimonabantIBA 07/2014 - 05/2001
4	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 10/2013 - 01/2000
4	Glucose (Dextrose)FDA LinkGeneric 05/2013 - 11/2007
4	Fatty Acids (Saturated Fatty Acids)IBA 11/2011 - 04/2000
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2010 - 08/2001
3	Analgesics (Analgesic Drugs)IBA 01/2017 - 04/2000
3	Proteins (Proteins, Gene)FDA Link 08/2015 - 04/2001
3	EnzymesIBA 07/2014 - 08/2001
3	CB2 Cannabinoid ReceptorIBA 10/2013 - 01/2000
3	Insulin (Novolin)FDA Link 05/2013 - 11/2007
3	Triglycerides (Triacylglycerol)IBA 05/2013 - 02/2009
3	Croton OilIBA 11/2008 - 10/2001
3	arvanilIBA 05/2007 - 10/2000
2	CytokinesIBA 11/2019 - 04/2000
2	2,4-dinitrofluorobenzene sulfonic acidIBA 11/2019 - 05/2013
2	Glycerol (Glycerine)FDA LinkGeneric 01/2017 - 11/2000
2	PlasticsIBA 01/2016 - 08/2015
2	Amino Acids FDA Link 08/2015 - 11/2001
2	Hormones (Hormone)IBA 11/2011 - 06/2001
2	Messenger RNA (mRNA)IBA 11/2011 - 03/2008
2	AmidesIBA 04/2011 - 11/2000
2	Therapeutic UsesIBA 06/2010 - 01/2010
2	arachidonoylserotoninIBA 04/2010 - 03/2007
2	Formaldehyde (Formol)FDA Link 11/2008 - 05/2000
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 07/2006 - 06/2001
2	Cannabinoid Receptor AgonistsIBA 07/2006 - 10/2001
2	LigandsIBA 04/2004 - 01/2000
2	Ouabain (G Strophanthin)IBA 05/2003 - 11/2001
2	Nerve Growth Factor (NGF)IBA 04/2000 - 01/2000
1	cannabidivarinIBA 11/2019
1	dinitrobenzenesulfonic acidIBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	methylglyoxal bis(3-aminopropylamidinohydrazone)IBA 01/2018
1	oleoylethanolamideIBA 01/2017
1	polydatinIBA 01/2017
1	GhrelinIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	TRPV Cation ChannelsIBA 01/2016
1	adelmidrolIBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	Glutamic Acid (Glutamate)FDA Link 08/2015
1	Neuropeptide YIBA 04/2015
1	Antipsychotic Agents (Antipsychotics)IBA 01/2014
1	malonic acid (malonate)IBA 10/2013
1	CholesterolIBA 05/2013
1	HDL LipoproteinsIBA 05/2013
1	LipidsIBA 05/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2013
1	NitritesIBA 05/2013
1	cannabichromeneIBA 05/2013

Therapy/Procedure

4	Analgesia 03/2007 - 10/2000
2	Therapeutics 08/2008 - 01/2007
1	Pain Management 01/2017